세계의 CRISPR 기술 시장

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

The global market for CRISPR technology in drug development application is expected to grow from $1.9 billion in 2024 to $3.8 billion by 2029, at a CAGR of 15.5% from 2024 to 2029.

The global market for CRISPR technology in agriculture application is expected to grow from $1.0 billion in 2024 to $2.0 billion by 2029, at a CAGR of 14.2% from 2024 to 2029.

Report Scope

This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.

Report Includes

• 32 data tables and 61 additional tables
• An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
• Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
• Discussion of the market potential for CRISPR technology
• Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
• Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
• A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
• A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
• Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
• A discussion on ESG challenges and ESG practices of the industry participants
• A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
• Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
• Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Genome Editing
• CRISPR
• Introduction
• Components of CRISPR
• Mechanism of Action
• CRISPR Gene Editing Workflow
• Advantages and Disadvantages of CRISPR Technology
• Pricing Analysis
• PESTLE Analysis
• Porter's Five Forces Analysis
• Regulatory Landscape, by Type
• Human
• Gene Drives
• Agriculture
• Animals
• Regulatory Landscape, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Rising Incidence of Chronic Diseases
• Prevalence of Genetic Disorders
• Government and Private Funding
• Market Restraints
• Alternative Technologies
• Market Opportunities
• Increase in the Number of Applications
• Market Challenges
• Complex and Evolving Regulatory Landscape
• High Cost of CRISPR-based Therapy

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies
• In Vivo Delivery of CRISPR
• Improved Cas Variants
• Artificial Intelligence
• Clinical Trials Analysis
• Clinical Trials Analysis, by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase
• Clinical Trials
• Patent Analysis
• Patents, by Year
• Patents, by Top Applicant
• Patents, by Top Owner
• Patents, by Jurisdiction
• Intellectual Property Disputes and Patent Issues

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown, by Application
• Drug Development
• Agriculture
• Diagnostics
• Other Applications
• Market Breakdown, by End User
• Biotech and Pharmaceutical Companies
• Academics and Government Research Institutes
• Contract Research Organizations
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Market Analysis
• Strategic Analysis

Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective

• Introduction to ESG
• Sustainability in CRISPR Technology: An ESG Perspective
• Key ESG Issues
• CRISPR Technology ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BEAM THERAPEUTICS
• CARIBOU BIOSCIENCES INC.
• CRISPR THERAPEUTICS
• DANAHER CORP.
• EDITAS MEDICINE
• GENSCRIPT
• INTELLIA THERAPEUTICS INC.
• LONZA
• MERCK KGAA
• THERMO FISHER SCIENTIFIC INC.